Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
Μaria Dalamaga, Ιrene Karampela, Christos S. Mantzoros
Topics & Concepts
Cytokine stormMedicineCytokineInflammationPneumoniaCytokine release syndromeImmunologyPharmacologyInterleukin 6Internal medicineCoronavirus disease 2019 (COVID-19)ImmunotherapyDiseaseImmune systemChimeric antigen receptorInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsLong-Term Effects of COVID-19